Archegos tried to lull banks before $36 bln firm collapsed - US prosecutors

By Jonathan Stempel

NEW YORK, Aug 19 (Reuters) - Archegos Capital Management LP made a last-ditch effort to falsely persuade banks its survival was not at stake in an unsuccessful bid to forestall the sudden collapse of the $36 billion private investment firm, U.S. prosecutors said.

The accusation came in a 12-page letter filed on Thursday night in Manhattan federal court, where Archegos' owner Sung Kook "Bill" Hwang has pleaded not guilty to 11 charges of fraud, market manipulation and racketeering conspiracy.

Prosecutors said Archegos misled banks dozens of times in the six months before its March 2021 demise about its liquidity and how concentrated its portfolio was, in order to borrow money and make huge bets on stocks through total return swaps.

The letter said Archegos' strained finances led to a March 24, 2021 meeting where senior executives including Hwang and co-defendant Patrick Halligan, then its chief financial officer, decided to falsely tell banks that the firm's inability to meet margin calls was "a liquidity issue, not a solvency issue."

Officials allegedly conveyed that assurance to Credit Suisse Group AG CSGN.S , Deutsche Bank AG DBKGn.DE , Goldman Sachs Group Inc GS.N , Morgan Stanley MS.N , Nomura Holdings Inc 8604.T and UBS Group AG UBSG.S that night and the next morning, and also misled counterparties about Archegos' cash.

Those counterparties began unwinding Archegos' positions on March 26, 2021. The New York firm's collapse caused about $10 billion of losses at banks including Credit Suisse and Nomura, and wiped out more than $100 billion of shareholder value.

Lawrence Lustberg, a lawyer for Hwang, said in an email the new accusations appeared to confirm that Hwang had "nothing to do" with any misrepresentations to banks. He also said he was confident the case would end in Hwang's "complete vindication."

Halligan's lawyer Mary Mulligan declined to comment. The banks declined to comment or had no immediate comment.

Prosecutors said the letter will give Hwang and Halligan, who has also pleaded not guilty to their April 2022 indictment, "awareness of the types - and often the very words - the government will use as examples" to prove their guilt at trial.

The next case conference is on Sept. 8. No trial date has been set.

The case is U.S. v. Hwang et al, U.S. District Court, Southern District of New York, No. 22-cr-00240.
Reporting by Jonathan Stempel in New York Additional reporting by Saeed Azhar Editing by David Holmes and Frances Kerry

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.